<?xml version="1.0" encoding="UTF-8"?><rss version="2.0">
    <channel>
        <title>ryortho.com</title>
        <link>http://ryortho.com</link>
        <description>Orthopedics This Week - Latest articles from ryortho.com</description>        
   
    <item>
        <title><![CDATA[Eden Spine’s Giza Receives Clearance]]></title>
        <pubDate>Fri, 03 Feb 2012 00:00:00 EST</pubDate>            
        <link>http://ryortho.com/spine.php?news=1724_Eden-Spines-Giza-Receives-Clearance</link>            
        <description><![CDATA[Eden Spine LLC has received FDA 510(k) clearance for its new corpectomy device. The Giza is indicated for vertebral body tumors and anterior column fractures]]></description>           
    </item>
   
    <item>
        <title><![CDATA[Treace’s Tricks to High Velocity Sales]]></title>
        <pubDate>Fri, 03 Feb 2012 00:00:00 EST</pubDate>            
        <link>http://ryortho.com/extremities.php?article=724_Treaces-Tricks-to-High-Velocity-Sales</link>            
        <description><![CDATA[Want to know the secrets of one of the greatest of all medical product sales managers? We did. So we read John Treace’s Nuts and Bolts. There are plenty of sales management books available but this is one of the best. Why? Think 30 years of medical sales management experience in a fast, practical read.]]></description>           
    </item>
   
    <item>
        <title><![CDATA[FRAX Use on the Rise]]></title>
        <pubDate>Thu, 02 Feb 2012 00:00:00 EST</pubDate>            
        <link>http://ryortho.com/trauma.php?news=1722_FRAX-Use-on-the-Rise</link>            
        <description><![CDATA[FRAX, a fracture risk assessment tool now available in 18 languages, is being used by an increasing number of physicians around the world. The online version alone is used to calculate 10-year probability of fracture in approximately 2.8 million patients annually. ]]></description>           
    </item>
   
    <item>
        <title><![CDATA[Industry/FDA Reach $595 Million Agreement on User Fees]]></title>
        <pubDate>Wed, 01 Feb 2012 00:00:00 EST</pubDate>            
        <link>http://ryortho.com/fda.php?news=1721_IndustryFDA-Reach-595-Million-Agreement-on-User-Fees</link>            
        <description><![CDATA[The FDA and industry have reached a $595 million agreement on device user fees. The agency says the new funding will speed up review times by allowing the hiring of over 200 more staffers. The $595 million over five years is an increase from the $295 million collected the previous five years. The agreement in principle now goes to Congress for a February 15 hearing.]]></description>           
    </item>
   
    <item>
        <title><![CDATA[Biologics to Fight Psoriatic Arthritis]]></title>
        <pubDate>Wed, 01 Feb 2012 00:00:00 EST</pubDate>            
        <link>http://ryortho.com/extremities.php?news=1719_Biologics-to-Fight-Psoriatic-Arthritis</link>            
        <description><![CDATA[A new review article in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) is shedding light on how medications or biologic agents that target T-cells appear to offer significant benefit to patients suffering from psoriatic arthritis (PsA).]]></description>           
    </item>
   
    <item>
        <title><![CDATA[Joint Replacement Blood Clot Threat Quantified]]></title>
        <pubDate>Wed, 01 Feb 2012 00:00:00 EST</pubDate>            
        <link>http://ryortho.com/largeJoints.php?news=1718_Joint-Replacement-Blood-Clot-Threat-Quantified</link>            
        <description><![CDATA[It has long been known that blood clots are a risk factor for patients undergoing replacement of their hips or knees. But just how great that risk is has been quantified by research out of the University Hospital of Lausanne, Switzerland.]]></description>           
    </item>
   
    <item>
        <title><![CDATA[Heroes Among Us]]></title>
        <pubDate>Wed, 01 Feb 2012 00:00:00 EST</pubDate>            
        <link>http://ryortho.com/spine.php?article=723_Heroes-Among-Us</link>            
        <description><![CDATA[All around the world, orthopedists give their time for free. One of these surgeons is Dr. Vincent Arlet, Chief of Orthopaedic Spine Services at the University of Pennsylvania, who travels to Trinidad several times a year to help Dr. David Toby, the only spinal deformity surgeon on the island. Together they handle massive spinal curves of 90 degrees or more. Read their story.]]></description>           
    </item>
   
    <item>
        <title><![CDATA[Korea FDA OK’s Stem Cell Drug]]></title>
        <pubDate>Tue, 31 Jan 2012 00:00:00 EST</pubDate>            
        <link>http://ryortho.com/biologics.php?news=1717_Korea-FDA-OKs-Stem-Cell-Drug</link>            
        <description><![CDATA[As Seoul-based Medipost officials predicted a few weeks ago, the Korea Food and Drug Administration has approved commercial sales of its drug using stem cells developed from newborn’s umbilical cord blood. ]]></description>           
    </item>
   
    <item>
        <title><![CDATA[FDA Clears Medtronic Hemostatic Sealer]]></title>
        <pubDate>Tue, 31 Jan 2012 00:00:00 EST</pubDate>            
        <link>http://ryortho.com/companyNews.php?news=1715_FDA-Clears-Medtronic-Hemostatic-Sealer</link>            
        <description><![CDATA[Medtronic, Inc. has received 510(k) clearance from the FDA for the Aquamantys SBS 5.0 Sheathed Bipolar Sealer. The tool allows surgeons to treat cut muscle planes as well as compress and treat epidural veins with a single device.]]></description>           
    </item>
   
    <item>
        <title><![CDATA[$89 Million for ConforMIS]]></title>
        <pubDate>Tue, 31 Jan 2012 00:00:00 EST</pubDate>            
        <link>http://ryortho.com/companyNews.php?news=1713_89-Million-for-ConforMIS</link>            
        <description><![CDATA[If new funds are like a hit of oxygen, then ConforMIS can breathe easily these days. The company is announcing that it has raised $89 million in a Series E round of funding—more than in any prior fundraising rounds. ]]></description>           
    </item>
    </channel>
</rss>

